Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 30th September 2025
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | 7.1% | 15.1% |
| 2025 |
|---|
| 7.1% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| - | 7.1% | 15.1% |
| 2025 |
|---|
| 7.1% |
Aristotle Atlantic's Core Equity Composite returned 7.22% gross in Q3 2025, underperforming the S&P 500's 8.12% return due to security selection challenges in Financials and Consumer Staples. The portfolio benefited from strong performance in Oracle, driven by transformative cloud infrastructure growth and multi-billion-dollar AI deals including the $30 billion Stargate contract with OpenAI. Energy transition themes gained traction through Constellation Energy, the largest U.S. carbon-free energy producer, which secured long-term power purchase agreements with tech companies. The manager added positions in Dexcom for diabetes device exposure and Baker Hughes for natural gas and LNG infrastructure opportunities. Key risks include elevated market valuations requiring lower rates and higher profits for further gains, ongoing tariff uncertainties affecting over 340 companies, and weakening employment trends. Trade policy showed mixed signals with progress on EU and Japan agreements but new tensions with India and Brazil. The outlook remains constructive on technology investment cycles, lower interest rates, and corporate profit growth, while maintaining company-level focus on secular tailwinds and product-driven cycles.
Aristotle Atlantic maintains a focus on investing in companies with secular tailwinds or strong product-driven cycles, emphasizing technology investment cycles, energy transition opportunities, and healthcare innovation while navigating elevated market valuations and trade policy uncertainties.
The equity markets rose to new highs on multiple expansion and higher earnings. A strong technology investment cycle, lower interest rates and growing corporate profits should continue to support higher equity prices. However, markets are trading at the upper end of historical valuation levels and will need a combination of lower rates and higher corporate profits to achieve new highs.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Nov 16 2025 | 2025 Q3 | ADPT, AMP, AR, AVGO, BDX, BKR, CEG, DAR, DXCM, GH, GOOGL, HAL, ICE, NOW, ORCL | AI, energy, growth, healthcare, large cap, nuclear, technology, Trade Policy |
DAR AR ORCL ADPT DXCM CEG BKR BDX |
Aristotle Atlantic underperformed in Q3 2025 despite strong Oracle gains from AI cloud deals and energy transition positioning through Constellation Energy. The manager added Dexcom and Baker Hughes while trimming software exposure. Markets face elevated valuations and tariff uncertainties, but technology investment cycles, Fed easing, and corporate earnings growth support the constructive outlook. |
| Jul 23 2025 | 2025 Q2 | AAPL, ADPT, AVGO, AWK, BDX, CB, EXPE, HAL, ORCL, TECH, TT, ZTS | AI, Cloud, earnings, healthcare, large cap, technology, Trade Policy, value |
ORCL AVGO BDX CB EXPE ZTS ORCL AVGO |
Strong Q2 outperformance driven by Oracle's cloud momentum and Broadcom's AI strength, offset by defensive rotation hurting Chubb and tariff concerns impacting Becton Dickinson. Manager trimmed travel and animal health exposure while maintaining focus on secular growth themes. Trade policy uncertainty and geopolitical tensions create macro headwinds, but corporate fundamentals remain solid with selective opportunities in technology. |
| Mar 31 2025 | 2025 Q1 | ADI, AR, AVGO, CHI, GH, ICE, NOW, ORCL, ORLY, TECH, VRTX | AI, large cap, semiconductors, technology, Trade Policy, value | ADI | Aristotle Atlantic underperformed in Q1 2025 due to AI infrastructure concerns following DeepSeek's release and trade policy uncertainty from new tariffs. Technology holdings Broadcom and ServiceNow detracted significantly. Despite strong corporate earnings growth of 17.8%, elevated market valuations and tariff-related headwinds create challenges. The manager continues focusing on secular growth themes through selective stock picking. |
| Dec 31 2024 | 2024 Q4 | AMP, AVMD, AVY, CHG, CI, CRWD, DAR, EXPE, GE, MCHP, NEE, SNOW, SPR, ZTS | aerospace, AI, cybersecurity, earnings, growth, industrials, large cap, technology |
GE CRWD |
Large-cap equity strategy outperformed via AI and cybersecurity exposure, adding Broadcom and CrowdStrike while trimming semiconductor laggards. Portfolio emphasizes technology leaders and industrial companies with competitive moats. Elevated valuations require earnings growth for further gains, with tariff and regulatory policy changes key market drivers ahead. |
| Sep 30 2024 | 2024 Q3 | AMAT, AR, EL, GH, GOOGL, HAL, HD, ICE, NEE, NSC, TT | energy, industrials, large cap, technology, Utilities, value |
AMAT HAL TT ICE |
Aristotle Atlantic underperformed in Q3 due to semiconductor and energy services headwinds, while benefiting from HVAC and exchange positions. The manager sold Estée Lauder amid China uncertainty. Despite elevated valuations and geopolitical risks, lower rates and earnings growth should support markets. Strategy focuses on companies with secular tailwinds. |
| Jul 10 2024 | 2024 Q2 | ABT, ACN, AME, APH, AVGO, BSX, COST, DAR, EL, GH, GOOGL, HAL, MCHP, NSC, NVDA, TFX | AI, growth, healthcare, large cap, semiconductors, technology |
NVDA GOOGL DAR NSC APH BSX MCHP |
Aristotle Atlantic outperformed in Q2 2024 driven by AI beneficiaries Nvidia and Alphabet, plus strong healthcare selections. Added positions in Amphenol, Boston Scientific, and Microchip Technology to capitalize on data center buildout, aging demographics, and industrial recovery. Despite elevated valuations and geopolitical risks, maintains focus on secular growth themes and company fundamentals. |
| Apr 15 2024 | 2024 Q1 | AAPL, ADPT, AMAT, DAR, GH, META, NVDA, TECH, TT, ZTS | consumer, growth, healthcare, large cap, semiconductors, technology, value |
NVDA DAR ZTS |
Aristotle Atlantic outperformed the S&P 500 in Q1 through strong security selection, benefiting from AI semiconductor exposure via Nvidia and an Apple underweight. Despite elevated valuations and geopolitical risks creating near-term uncertainty, the manager expects higher earnings and rate cuts to support markets while focusing on companies with secular tailwinds. |
| Feb 26 2024 | 2023 Q4 | AR, AVGO, BDX, BMY, CHH, DAR, EXPE, HAL, LLY, NOW, PEP, SPR, TFX, VRTX | earnings, energy, healthcare, large cap, technology, value |
ALLY MELI|NFLX|ORCL|TCOM|VRTX|YUMC |
Aristotle Atlantic outperformed in Q4 through strong stock selection, particularly in AI-exposed Broadcom and restructuring Spirit AeroSystems. Added pharmaceutical leaders Eli Lilly and Vertex while exiting Bristol-Myers and PepsiCo. Expects 2024 Fed cuts and earnings growth to broaden performance beyond AI, but elevated valuations and geopolitical risks present challenges. |
| Sep 30 2023 | 2023 Q3 | CB, DAR, DG, HAL, MCHP, META, ORCL, SPR | energy, growth, inflation, large cap, rates, technology, value |
COO|CW|DKNG|FSS|HALO|ZD 0MCB LN ALDAR.AD ESPR ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO |
Aristotle Atlantic underperformed in Q3 as rising rates pressured markets. Energy holdings like Halliburton outperformed on higher oil prices while leveraged names like Darling Ingredients struggled. Added Oracle and Meta for AI exposure. Expects economic slowing but maintains company-specific focus on secular growth drivers rather than macro positioning. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q3 |
AIOracle's transformative growth in cloud infrastructure driven by AI demand, with Oracle Cloud Infrastructure revenue expected to grow through fiscal 2030. The company closed multiple multi-billion-dollar deals including the $30 billion Stargate contract with OpenAI. Natural gas demand is increasing for AI data center power generation, benefiting companies like Antero Resources. |
Data Centers Cloud Natural Gas Infrastructure OpenAI |
Energy TransitionConstellation Energy positioned as the largest producer of carbon-free energy in the United States, operating the nation's largest nuclear fleet. The company benefits from favorable legislation providing tax credits for nuclear energy and is securing long-term power purchase agreements with major tech companies. Nuclear energy is validated as a preferred clean power source for large-scale operations and data centers. |
Nuclear Clean Energy Power Purchase Agreements Decarbonization Electrification | |
Natural GasBaker Hughes well-positioned to capitalize on rising global demand for natural gas and LNG projects, benefiting from its LNG franchise and critical turbomachinery. Antero Resources faces near-term challenges from lower natural gas prices and pipeline constraints, but long-term outlook remains positive due to increasing demand for AI data center power generation and growing U.S. LNG export infrastructure. |
LNG Gas Producers Energy Infrastructure Export Infrastructure Turbomachinery | |
BiotechnologyAdaptive Biotechnologies showing momentum in its minimal residual disease testing business, anchored by its flagship clonoSEQ test for MRD in hematological cancers. The company reported better-than-expected earnings and raised full-year guidance, with average selling price increases complementing accelerating volume growth. Dexcom added as a new position in continuous glucose monitoring systems for diabetes management. |
Medical Devices Diagnostics Diabetes Oncology Healthcare | |
Trade PolicyTrade-related concerns eased somewhat with progress on multiple agreements. The EU agreed to pay the U.S. a 15% tariff rate and committed to purchase $750 billion in U.S. energy. Japan agreed to a baseline 15% tariff and committed to purchasing $8 billion annually in U.S. agricultural goods. However, tensions persisted with additional tariffs on Indian and Brazilian imports. |
Tariffs Trade Agreements Energy Exports Agricultural Exports International Trade | |
| 2025 Q2 |
Trade PolicyPresident Trump introduced a universal 10% import tariff and reciprocal tariffs on dozens of countries as part of Liberation Day, followed by a 90-day pause on reciprocal tariffs to encourage negotiations. The U.S. and U.K. finalized the Economic Prosperity Deal, while negotiations continued with the EU, Japan, Canada and India. More than 425 companies referenced tariffs in earnings calls and nearly 12% issued negative EPS guidance for the quarter ahead. |
Tariffs Trade Negotiations Imports Policy |
AIBroadcom reported strong quarterly results for its AI compute and networking business, with positive commentary on the setup for AI-related silicon business units for the rest of 2025 and 2026. Strong customer demand for AI silicon for training and inference continues to drive performance. |
Artificial Intelligence Compute Silicon Training Inference | |
CloudOracle highlighted continued strong demand for the company's OCI infrastructure, sustained growth in the SaaS apps business, and accelerating growth trends in the cloud database segment. Management highlighted RPO growth of over 100%, which speaks to continuing demand for Oracle's infrastructure and software products over a multi-year period. |
Infrastructure SaaS Database Software Growth | |
| 2025 Q1 |
AIThe DeepSeek AI model release stunned investors and raised concerns about rapid decline in AI model development costs and effects on capex spending for new infrastructure and advanced semiconductors. The entire AI infrastructure investment space saw significant declines following DeepSeek announcements. Intercontinental Exchange highlighted new AI solutions in its Mortgage Technology product suite to improve and digitize workflows. |
AI Infrastructure Capex DeepSeek Semiconductors Mortgage Technology |
Trade PolicyPresident Trump announced new tariffs on imports from Canada, Mexico and China, citing concerns over illegal immigration, drug trafficking and intellectual property theft. Targeted industries included autos, steel, aluminum and energy, particularly Venezuelan oil. More than 220 companies referenced tariffs in earnings calls and nearly 15% issued negative earnings guidance. |
Tariffs Trade China Mexico Canada | |
SemiconductorsBroadcom detracted from performance as concerns about AI model development costs affected capex spending for advanced semiconductors used for accelerated computing. The entire AI infrastructure investment space saw significant declines. Analog Devices was added to the portfolio as a global semiconductor leader providing exposure to high-growth trends including automotive electrification and factory automation. |
Semiconductor Cycle AI Infrastructure Automotive Factory Automation Capex | |
| 2024 Q4 |
AIBroadcom demonstrated continuing strength in AI networking and custom accelerator semiconductor business with long-term guidance indicating $60-90 billion market opportunity from current three customers. The company exceeded investor expectations for AI semiconductor content and is ahead on VMware integration timeline. |
Semiconductors Networking Data Centers Cloud Infrastructure VMware |
CybersecurityCrowdStrike positioned to benefit from cloud cybersecurity market growth driven by migration from on-premises to cloud-based architecture. Increasing threats from state-sanctioned cybercriminals using AI necessitate higher spending on advanced cybersecurity products with significant total addressable market growth projected. |
Cloud Endpoint Protection Threat Intelligence Enterprise Software SaaS | |
AerospaceGE Aerospace benefits from high entry barriers in concentrated industry with steady demand from Boeing and Airbus order books. Company expects high single-digit revenue growth with $10 billion annual operating profit target by 2028 and 20% annual earnings growth following restructuring. |
Defense Commercial Aviation Aircraft Engines Aerospace Components Defense Components | |
| 2024 Q3 |
SemiconductorsApplied Materials faced investor pullback in AI-related semiconductor names due to concerns about AI market growth and profitability of massive capex investments. The company continues to benefit from secular shift to highly complex semiconductors design and manufacturing, but faces weakness in NAND manufacturing and potential trade restrictions on Chinese equipment purchases. |
AI Semiconductor Cycle China |
Energy ServicesHalliburton reported weakening North American market for its services, with guidance showing slower market continuing through year-end. Manager believes 2024 will mark the trough for North American market and expects benefit from improving natural gas prices and newly consolidated customers seeking high-quality offerings. |
Oil Services Natural Gas North America | |
HVACTrane Technologies showed strength in commercial business related to improving energy efficiency demand and additional cooling opportunities in data centers. The residential business is beginning to recover after a period of weakness. |
Data Centers Energy Efficiency Commercial Real Estate | |
Data CentersIntercontinental Exchange benefited from energy trading activity expected to remain elevated, primarily bolstered by increasing data center-driven electricity demand. Data centers also present cooling opportunities for HVAC companies like Trane Technologies. |
Energy Trading Electricity Infrastructure | |
| 2024 Q2 |
AIAI continues to drive market gains with the Magnificent 7 responsible for the majority of S&P 500 returns. Nvidia sees accelerating demand for GPU semiconductors from hyperscalers and enterprises for AI computing. Amphenol benefits from increased spending on AI-enabled data center architectures requiring higher interconnect content. |
Data Centers Semiconductors Cloud GPUs Computing |
Medical DevicesBoston Scientific benefits from strong utilization trends post-COVID, positive demographic trends with aging patients, and new product innovation to gain market share. The company executed well against its long-range plan calling for 8-10% organic sales growth and 150 basis points of operating margin expansion through 2026. |
Healthcare Demographics Innovation Market Share Growth | |
SemiconductorsMicrochip Technology's Total System Solution supports industry share gains and margin expansion as end-market demand for industrial and Internet of Things compute needs begins to recover. Management accelerated drawdown of high customer inventory levels and current industry data indicates early signs of improvement. |
Industrial IoT Recovery Inventory Margins | |
| 2024 Q1 |
AINvidia continues to see accelerating demand for its GPU semiconductors from hyperscalers and enterprises. The company's GPU semiconductors continue to be the building blocks of the accelerated computing data-center architecture to drive AI compute and applications. Apple has yet to demonstrate a competitive AI product, which could present further competitive headwinds. |
GPU Data Centers Semiconductors Computing Enterprise |
Sustainable Aviation FuelDarling Ingredients remains confident in the discussions it is having with global cargo and passenger air carriers about takeaway agreements for its planned sustainable aviation fuel production. Any announcement could prove to be a catalyst given the depressed valuation currently. |
Aviation Biofuels Airlines Energy Transition | |
| 2023 Q4 |
AIBroadcom reported strength in its AI business segments during Q4. The company provided positive fiscal year 2024 guidance that included synergy target goals ahead of schedule for the combined businesses following the VMware acquisition. |
AI Semiconductors VMware Synergies |
PharmaceuticalsAdded Eli Lilly for its deep pipeline in metabolic disorders, oncology, immunology and CNS disorders, with Mounjaro having potential beyond diabetes and obesity. Added Vertex Pharmaceuticals as the global leader in cystic fibrosis treatment with a robust pipeline. Sold Bristol-Myers due to reduced medium-term guidance on new product portfolio. |
GLP1 Diabetes Oncology Pipeline | |
| 2023 Q3 |
OilOil prices hit their highest level of the year with both WTI and Brent eclipsing $90 a barrel. Higher commodity prices benefited companies like Halliburton as supply concerns and improving supply-demand fundamentals in 2024 drive growth expectations. |
WTI Brent Supply Demand Pricing |
AIThe rapid growth of artificial intelligence computing needs is seen as a differentiated growth driver for Oracle. Meta is leveraging AI and machine learning technology to accelerate development of targeted digital advertising capabilities. |
Computing Machine Learning Advertising Technology | |
RatesThe Federal Reserve held interest rates steady at 5.25% to 5.50% in September after raising them in July. Rising interest rates negatively impacted equity markets and pressured companies with outsized leverage like Darling Ingredients. |
Federal Reserve Monetary Policy Leverage Credit |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2023 | Fund Letters | Aristotle Atlantic Core Equity Strategy | COO|CW|DKNG|FSS|HALO|ZD | Halliburton Company | Energy | Oil & Gas Equipment & Services | Bull | NYSE | commodity prices, Drilling, energy, International, Margins, North America, Oil & Gas Equipment, oilfield services, technology | Login |
| Sep 30, 2023 | Fund Letters | Aristotle Atlantic Core Equity Strategy | 0MCB LN | Chubb Limited | Financials | Property & Casualty Insurance | Bull | NYSE | financials, Global, Insurance, Pricing, Property & Casualty, risk assessment, underwriting, valuation | Login |
| Sep 30, 2023 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ALDAR.AD | Darling Ingredients Inc. | Materials | Chemicals | Bear | NYSE | Acquisitions, Biofuels, Chemicals, deleveraging, Fire, Interest rates, leverage, materials, Production | Login |
| Sep 30, 2023 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ESPR | Spirit AeroSystems Holdings, Inc. | Industrials | Aerospace & Defense | Bear | NYSE | 737 Max, 787, A220, A350, Aerospace, Airbus, Boeing, CEO change, manufacturing, Quality Issues | Login |
| Sep 30, 2023 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO | Oracle Corporation | Information Technology | Systems Software | Bull | NASDAQ | Artificial Intelligence, Cerner, cloud infrastructure, Database, Enterprise software, Oci, SaaS, synergies, technology | Login |
| Sep 30, 2023 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ADI|BDX|FI|FND|HAS|META|MSFT|MSI|ORCL|TMO | Meta Platforms, Inc. | Communication Services | Interactive Media & Services | Bull | NASDAQ | Artificial Intelligence, digital advertising, efficiency, Messenger, Olympics, Political advertising, Reels, social media, technology, user engagement | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | DAR | Darling Ingredients Inc. | Consumer Staples | Packaged Foods & Ingredients | Bear | NYSE | Biofuels, Margins, Regulation, Renewable diesel, Sentiment | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | AR | Antero Resources Corporation | Energy | Oil & Gas Exploration & Production | Bull | NYSE | AI demand, Basis, Cyclicality, LNG, natural gas | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | ORCL | Oracle Corporation | Information Technology | Application Software | Bull | NYSE | AI, cloud, Contracts, Oci, visibility | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | ADPT | Adaptive Biotechnologies Corporation | Health Care | Medical Technology | Bull | NASDAQ | Clonoseq, diagnostics, guidance, Mrd, Volumes | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | DXCM | DexCom, Inc. | Health Care | Medical Devices | Bull | NASDAQ | Cgm, Diabetes, growth, innovation, Reimbursement | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | CEG | Constellation Energy Corporation | Utilities | Electric Power & Renewable Energy | Bull | NASDAQ | AI, clean energy, Decarbonisation, Nuclear, Ppas | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | BKR | Baker Hughes Company | Energy | Oil & Gas Equipment & Services | Bull | NASDAQ | backlog, LNG, Margins, Transition, Turbines | Login |
| Nov 16, 2025 | Fund Letters | Owen Fitzpatrick, Thomas Hynes, Jr, Brendan O’Neill | BDX | Becton, Dickinson and Company | Health Care | Medical Instruments & Supplies | Bear | NYSE | de-risking, divestiture, Funding, guidance, Medtech | Login |
| Jul 23, 2025 | Fund Letters | Owen Fitzpatrick | ORCL | Oracle Corporation | Information Technology | Systems Software | Bull | NYSE | backlog, buybacks, cloud, infrastructure, Margins, Recurring, SaaS, Software | Login |
| Jul 23, 2025 | Fund Letters | Owen Fitzpatrick | AVGO | Broadcom Inc. | Information Technology | Semiconductors | Bull | NASDAQ | AI, buybacks, diversification, dividend, Freecashflow, Margins, Networking, semiconductors | Login |
| Jul 23, 2025 | Fund Letters | Owen Fitzpatrick | BDX | Becton, Dickinson and Company | Health Care | Health Care Supplies | Bear | NYSE | diagnostics, Funding, growth, guidance, Margins, Medtech, Policy, tariffs | Login |
| Jul 23, 2025 | Fund Letters | Owen Fitzpatrick | CB | Chubb Limited | Financials | Property & Casualty Insurance | Bear | NYSE | Capital, Insurance, Margins, premiums, Pricing, Rotation, underwriting, valuation | Login |
| Jul 23, 2025 | Fund Letters | Owen Fitzpatrick | EXPE | Expedia Group, Inc. | Consumer Discretionary | Hotels, Resorts & Cruise Lines | Bear | NASDAQ | Competition, Cyclical, Demand, Margins, recession, tariffs, Travel, Volatility | Login |
| Jul 23, 2025 | Fund Letters | Owen Fitzpatrick | ZTS | Zoetis Inc. | Health Care | Pharmaceuticals | Bear | NYSE | Animalhealth, Competition, Demand, growth, Margins, portfolio, Pricing, valuation | Login |
| Jun 30, 2025 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ORCL | Oracle Corporation | Software & Services | Systems Software | Bull | NASDAQ | Cloud computing, cloud infrastructure, Database, Enterprise software, RPO growth, SaaS, technology | Login |
| Jun 30, 2025 | Fund Letters | Aristotle Atlantic Core Equity Strategy | AVGO | Broadcom Inc. | Semiconductors & Semiconductor Equipment | Semiconductors | Bull | NASDAQ | AI compute, AI silicon, inference, Networking, semiconductors, technology, Training, Vmware | Login |
| Mar 31, 2025 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ADI | Analog Devices | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | Analog, Automotive electrification, Edge computing, Equity, Factory Automation, Free Cash Flow, IoT, mixed-signal, semiconductors, sustainable energy | Login |
| Dec 31, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | GE | GE Aerospace | Industrials | Aerospace & Defense | Bull | NYSE | Aerospace, aftermarket, Aircraft engines, capital allocation, Defense, High Barriers, restructuring, services | Login |
| Dec 31, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | CRWD | CrowdStrike Holdings | Information Technology | Systems Software | Bull | NASDAQ | AI threats, cloud, customer retention, cybersecurity, Early-Mover, endpoint protection, platform, SaaS | Login |
| Sep 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | AMAT | Applied Materials | Information Technology | Semiconductor Equipment | Bull | NASDAQ | AI infrastructure, China, Chip Production, Materials Engineering, NAND Manufacturing, semiconductor equipment, Trade Restrictions | Login |
| Sep 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | HAL | Halliburton | Energy | Oil & Gas Equipment & Services | Bull | NYSE | cyclical trough, industry consolidation, international markets, natural gas, North America, Offshore, Oil Services, valuation | Login |
| Sep 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | TT | Trane Technologies | Industrials | Building Products | Bull | NYSE | Climate Solutions, Commercial Buildings, Cooling Systems, data centers, energy efficiency, HVAC, Residential Recovery | Login |
| Sep 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ICE | Intercontinental Exchange | Financials | Financial Exchanges & Data | Bull | NYSE | data centers, electricity demand, Energy Futures, Financial Exchanges, Housing recovery, Interest Rate Futures, Mortgage Technology | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | NVDA | Nvidia | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | Accelerated Computing, AI, data centers, Gpu, hyperscalers, semiconductors, technology | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | GOOGL | Alphabet | Communication Services | Interactive Media & Services | Bull | NASDAQ | advertising, AI monetization, dividend, GenAI, Search, Share Buybacks, technology | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | DAR | Darling Ingredients | Consumer Staples | Food Products | Bull | NYSE | Biofuels, energy transition, Feedstocks, Margins, Renewable diesel, Sustainable aviation fuel, tax credits | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | NSC | Norfolk Southern | Industrials | Road & Rail | Bear | NYSE | activist investor, Governance, Operational Performance, proxy battle, Railcar Volumes, railroad, Transportation | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | APH | Amphenol | Information Technology | Electronic Equipment, Instruments & Components | Bull | NYSE | AI infrastructure, Connectors, data centers, Free Cash Flow, hyperscalers, Interconnects, M&A | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | BSX | Boston Scientific | Health Care | Health Care Equipment & Supplies | Bull | NYSE | Aging Population, cardiovascular, Demographics, innovation, margin expansion, Medical devices, Utilization Recovery | Login |
| Jun 30, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | MCHP | Microchip Technology | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | Cyclical Recovery, Electric Vehicles, Embedded Control, Industrial, IoT, margin expansion, Total System Solution | Login |
| Mar 31, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | NVDA | Nvidia Corporation | Information Technology | Semiconductors & Semiconductor Equipment | Bull | NASDAQ | AI, Computing, data center, Gpu, hyperscalers, semiconductors, technology | Login |
| Mar 31, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | DAR | Darling Ingredients Inc. | Materials | Chemicals | Bull | NYSE | Airlines, Bioenergy, Chemicals, EBITDA, Renewable fuels, Sustainable aviation fuel, Waste-to-Energy | Login |
| Mar 31, 2024 | Fund Letters | Aristotle Atlantic Core Equity Strategy | ZTS | Zoetis Inc. | Health Care | Pharmaceuticals | Bull | NYSE | Animal Health, Companion Animals, Livestock, Pet Ownership, pharmaceuticals, Protein Demand, Veterinary | Login |
| - | Fund Letters | Aristotle Atlantic Core Equity Strategy | ALLY | Eli Lilly & Company | Health Care | Pharmaceuticals | Bull | NYSE | Biotech, Diabetes, GLP-1, Immunology, Metabolic Disorders, Obesity, Oncology, pharmaceuticals, pipeline | Login |
| - | Fund Letters | Aristotle Atlantic Core Equity Strategy | MELI|NFLX|ORCL|TCOM|VRTX|YUMC | Vertex Pharmaceuticals | Health Care | Biotechnology | Bull | NASDAQ | biotechnology, cash-rich, Cystic fibrosis, Monopoly, Pain Management, pipeline, rare diseases, Sickle Cell Disease | Login |
| TICKER | COMMENTARY |
|---|---|
| ORCL | Oracle contributed to performance in the third quarter due to its transformative growth in cloud infrastructure, with management announcing that Oracle Cloud Infrastructure (OCI) revenue would grow this fiscal year and then increase through fiscal 2030. The stock surged following the closure of multiple multi-billion-dollar deals, including the $30 billion Stargate contract with OpenAI. Additionally, remaining performance obligation (RPO) growth reached 359%, providing investors with greater visibility into future revenue streams. |
| DAR | Darling Ingredients detracted from performance in the third quarter as uncertainty around the timelines for the U.S. Environmental Protection Agency (EPA) finalizing the proposed Renewable Volume Obligations (RVOs) weighed on sentiment. In September, there was favorable news that the EPA was proposing to reallocate some of the credits forgiven under the Small Refinery Exemption (SRE), which could raise the ultimate RVOs into next year and thus enable a more favorable backdrop for margins on renewable diesel. We believe that 2025 has played out with positive catalysts for Darling; however, the lack of finalization of the proposals led to investors being in more of a wait-and-see mode. |
| ADPT | Adaptive Biotechnologies contributed to performance in the third quarter as momentum continued in its minimal residual disease (MRD) testing business, anchored by its flagship clonoSEQ test for MRD in several hematological cancers. During the quarter, the company reported better-than-expected earnings and raised full-year guidance. Average selling price (ASP) increases are complementing accelerating volume growth. |
| AR | Antero Resources detracted from performance in the third quarter due to lower natural gas prices causing earnings volatility as a result of the company's unhedged production profile. In addition, pipeline constraints and seasonal infrastructure limitations caused Antero's gas realizations to trade at steep discounts to NYMEX benchmarks despite strong operational execution. The long-term outlook for natural gas demand continues to skew positively due to increasing demand for natural gas for AI data center power generation, as well as growing U.S. LNG export infrastructure. |
| DXCM | Our investment case for Dexcom is compelling due to its strong financial health, including a clean balance sheet and robust free cash flow generation. The company is experiencing significant growth, with organic revenue increasing in fiscal 2025 and earnings growth projected to continue over the next several years. The company is expanding its market reach with the successful launch of Stelo, a CGM for non-diabetics, and the transition to the G7 system, which offers a longer sensor life. Additionally, Dexcom is targeting the large and growing non-intensive type 2 diabetes market and continues to benefit from positive reimbursement trends. |
| CEG | We see Constellation well-positioned as a leading player in the energy sector, with excellent operational performance, strong cash flow generation and significant financial flexibility. The company benefits from favorable legislation like the One Big Beautiful Bill Act, which provides tax credits for nuclear energy and support for clean hydrogen. Additionally, the company is expanding its nuclear fleet at low cost, securing long-term power purchase agreements (PPAs) with major tech companies and enhancing its asset mix through strategic acquisitions. These factors collectively validate nuclear energy as a preferred clean power source for large-scale operations and data centers. |
| BKR | We believe Baker Hughes is well-positioned to capitalize on the rising global demand for natural gas and LNG projects, benefiting from its LNG franchise and critical turbomachinery. The company is also improving its margins and cash flow conversion, with EBITDA margins projected to be high teens in 2025 and targeting ~20%+ over the next few years. Additionally, Baker Hughes is accelerating its AI data center power infrastructure buildout, leveraging its NovaLT series gas turbines. The company's diversified business model, including its industrial technology arm, provides stable revenue streams. |
| BDX | We sold Becton Dickinson following weakness related to its recent fiscal earnings quarter, where results showed impact from cuts to certain programs funded by the National Institutes of Health (NIH). The company cut forward earnings and revenue guidance to reflect weakness in funding for biosciences research and development (R&D) and the expected impacts of tariffs. While Becton is attempting to divest its Biosciences and Diagnostic Solutions divisions, we are not confident that it will attain the best value given the cyclical downturn affecting these businesses. |
| NOW | We sold ServiceNow and reduced our subsector overweight to Software, as we continue to see areas of risk from macroeconomic headwinds and seat-based spending pressure due to budgetary shifts within software spend to agentic AI and LLM-leveraged software. |
| HAL | We sold Halliburton to fund the investment in Baker Hughes. We believe that the company's U.S. completion and pumping business will face longer-than-expected headwinds from declining U.S. onshore activity and pricing weakness. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||